Microbial products are surveyed that have an immunoregulatory activity, both from the realm of low-molar-mass compounds and from the group of naturally occurring polymers. The data include in most cases the producer organism or source, a brief chemical characteristic and biological activity. Various groups of substances are compared, the drawbacks attendant on their acquisition and application are pointed out and their advantageous properties are specified.

Institute of Microbiology Czechoslovak Academy of Sciences Prague

See more in PubMed

J Antibiot (Tokyo). 1987 Sep;40(9):1249-55 PubMed

J Antibiot (Tokyo). 1986 Aug;39(8):1155-9 PubMed

J Antibiot (Tokyo). 1982 Aug;35(8):1049-54 PubMed

Cancer Immunol Immunother. 1987;25(2):111-8 PubMed

J Antibiot (Tokyo). 1981 Dec;34(12):1622-4 PubMed

Jpn J Cancer Res. 1985 Nov;76(11):1091-8 PubMed

J Antibiot (Tokyo). 1986 Aug;39(8):1148-54 PubMed

Czech Med. 1987;10(2):90-8 PubMed

Folia Microbiol (Praha). 1985;30(3):258-66 PubMed

J Antibiot (Tokyo). 1971 Sep;24(9):631-5 PubMed

Cancer Immunol Immunother. 1987;25(2):119-25 PubMed

Antibiot Khimioter. 1989 Oct;34(10):786-92 PubMed

Cancer. 1986 Apr 15;57(8):1483-8 PubMed

J Antibiot (Tokyo). 1983 Aug;36(8):1045-50 PubMed

J Antibiot (Tokyo). 1978 Jun;31(6):639-41 PubMed

J Antibiot (Tokyo). 1981 Dec;34(12):1619-21 PubMed

J Antibiot (Tokyo). 1988 Nov;41(11):1592-601 PubMed

J Antibiot (Tokyo). 1987 Mar;40(3):363-9 PubMed

J Immunol. 1985 Nov;135(5):3277-83 PubMed

Transplant Proc. 1987 Oct;19(5 Suppl 6):11-6 PubMed

Antibiot Med Biotekhnol. 1985 Feb;30(2):131-8 PubMed

Folia Microbiol (Praha). 1985;30(3):231-6 PubMed

J Antibiot (Tokyo). 1984 Dec;37(12):1738-40 PubMed

Gan. 1976 Oct;67(5):733-6 PubMed

J Antibiot (Tokyo). 1989 Feb;42(2):312-6 PubMed

J Antibiot (Tokyo). 1978 Jun;31(6):636-8 PubMed

J Antibiot (Tokyo). 1987 May;40(5):612-22 PubMed

Arch Biochem. 1949 Jul;22(3):476-8 PubMed

J Antibiot (Tokyo). 1981 Mar;34(3):331-40 PubMed

J Antibiot (Tokyo). 1989 Jun;42(6):952-9 PubMed

Br J Surg. 1986 Jul;73(7):589-90 PubMed

J Antibiot (Tokyo). 1980 Dec;33(12):1594-6 PubMed

J Immunol. 1979 Jun;122(6):2418-23 PubMed

J Antibiot (Tokyo). 1978 Mar;31(3):244-6 PubMed

J Antibiot (Tokyo). 1982 Oct;35(10 ):1293-9 PubMed

Infect Immun. 1976 Apr;13(4):1084-90 PubMed

J Antibiot (Tokyo). 1976 Jan;29(1):97-9 PubMed

Infect Immun. 1975 Feb;11(2):257-64 PubMed

J Antibiot (Tokyo). 1982 Nov;35(11):1618-20 PubMed

J Antibiot (Tokyo). 1983 Aug;36(8):1051-8 PubMed

J Antibiot (Tokyo). 1986 Apr;39(4):569-74 PubMed

Cancer Immunol Immunother. 1986;22(2):148-54 PubMed

Cancer Res. 1983 Nov;43(11):5575-9 PubMed

J Antibiot (Tokyo). 1989 Feb;42(2):236-41 PubMed

J Antibiot (Tokyo). 1980 Jun;33(6):653-62 PubMed

Infect Immun. 1978 Feb;19(2):353-6 PubMed

Jpn J Cancer Res. 1986 Apr;77(4):406-12 PubMed

Helv Chim Acta. 1967 Apr 20;50(3):731-53 PubMed

J Antibiot (Tokyo). 1982 Oct;35(10 ):1286-92 PubMed

Cancer Res. 1986 Apr;46(4 Pt 2):1960-5 PubMed

The polybacterial lysate Olimunostim modulates lymphocyte function in vitro and restores depressed cellular immunity in vivo